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Yang Yang, Li-chao Zhang, Fei Xu, Jia Li and Yong-ming Lv*Abstract
Introduction: To assess whether bipolar sealer has advantages over standard electrocautery in primary total hip
arthroplasty (THA).
Methods: All studies published through November 2013 were systematically searched in PubMed, Embase,
ScienceDirect, The Cochrane Library, and other databases. Relevant journals or conference proceedings were
searched manually. Only randomized controlled trials were included. Two independent reviewers identified and
assessed the literature. Mean difference in blood loss and risk ratios of transfusion rates and of complication rates
in the bipolar sealer group versus the standard electrocautery group were calculated. The meta-analysis was
conducted using RevMan 5.1 software.
Results: Five studies were included, with a total sample size of 559 patients. The use of bipolar sealer did not
significantly reduce intraoperative blood loss, hemoglobin drop, hospital stay, and operative time. There were no
significant differences in need for transfusion and the incidence of infection between the study groups.
Conclusion: The available evidence suggests that the use of bipolar sealer was not superior to standard
electrocautery in patients undergoing primary THA. The use of bipolar sealer is not recommended in primary THA.
Keywords: Hip arthroplasty, Bipolar sealer, Hemostasis, Meta-analysisIntroduction
Total hip arthroplasty (THA) has become a common
treatment for hip disorders such as severe osteoarthritis,
rheumatoid arthritis, femoral head necrosis, and femoral
neck fractures. Because of extensive soft tissue dissection,
long operative times, and operation on the bone, patients
undergoing primary THA are particularly prone to large
blood loss, from 1,000 to 2,000 ml [1-4].
Several blood-preservation techniques are in regular
clinical use: hemostatic agents, erythropoietic agents, min-
imally invasive surgery, intraoperative and postoperative
salvage of blood with reinfusion, hypotensive or epidural
anesthesia, and preoperative autologous blood donation
[5-7]. Generally speaking, patients need blood transfusion
because of intra- and/or postoperative blood loss. Trans-
fused patients are exposed to risks such as adverse* Correspondence: yangyangchengde@gmail.com
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unless otherwise stated.immunological reactions, disease transmission, intravascu-
lar hemolysis, transfusion-induced coagulopathy, renal im-
pairment or failure, and even increased mortality [8-10].
Effective hemostasis in THA results in lower risk of blood
transfusion and, therefore, faster postoperative recovery
and lower medical costs.
Standard electrocautery is commonly adopted to achieve
intraoperative hemostasis. However, standard electro-
cautery has been reported to cause severe burns and severe
tissue necrosis in patients, and operating room fires; more-
over, viruses and carcinogens have been detected in the
smoke generated by the device during surgery [11-14]. In
addition, investigators have also noted that skin incision
healing is quite slow, because of which, they argued, appli-
cation of electrocautery should be limited to reduce the
postoperative complications [15]. Compared with conven-
tional electrocautery, bipolar sealer may achieve hemostasis
at 100°C or lower temperatures. Bipolar sealer avoids char-
ring or burning tissue, does not produce smoke, and mayd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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sealing and coagulation of soft tissue [16]. Consequently, it
is favored in hepatic transplantations, cirrhotic liver resec-
tions, cholecystectomies, and oncological surgery.
To our knowledge, numerous prospective randomized
controlled trials (RCTs) have focused on the use of bipo-
lar sealer in primary THA. However, the results are not
consistent. Studies have been criticized for poor design
and small sample size with consequently low power.
Therefore, we conducted a meta-analysis, pooling the
data from RCTs to provide an evidence-based judgment




We conducted a meta-analysis to identify academic arti-
cles from electronic databases, including MEDLINE (1966
to November 2013), Embase (1980 to November 2013),
and The Cochrane Central Register of Controlled Trials.
There were no language restrictions. The search strategy
is presented in Figure 1. It included only studies con-
ducted on human subjects. In addition, using the Google
search engine, the same search terms were manually
searched to find any further relevant studies that may haveRecords identified through 
database searching  
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Figure 1 Flowchart of the study selection.been missed in the database search. We used the following
key words: “hip replacement OR arthroplasty” and “bi-
polar sealer” in combination with Boolean operators
AND or OR.
Selection criteria and quality assessment
We included all published RCTs and quasi-RCTs (trials
using a method of allocating participants to a treatment
that is not strictly random, e.g., by date of birth, hospital
record number, alternation) comparing the bipolar
sealer with standard electrocautery in patients undergo-
ing THA. Exclusion criteria comprised the following
(by implication): trials with retrospective design, those
without randomization of patients into two relevant
groups, together with studies focusing on an orthopedic.
The methodological quality of the included studies was
assessed by the review authors using a modification of
the generic evaluation tool used by the Cochrane Bone,
Joint and Muscle Trauma Group. To provide a qualifica-
tion of bias risk, quality criteria included (i) details of
randomization method, (ii) allocation concealment, (iii)
blinding of participants and personnel, (iv) blind out-
come assessment, (v) incomplete outcome data, (vi)
selective outcome reporting, and (vii) other sources of
bias.Additional records identified 
through other sources  
( n =0 ) 
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Figure 2 Methodological quality of the included studies. This
risk-of-bias tool incorporates assessment of randomization (sequence
generation and allocation concealment), blinding (participants,
personnel and outcome assessors), completeness of outcome data,
selection of outcomes reported, and other sources of bias. The items
were scored with “yes”, “no”, or “unsure”.
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For each eligible study, two of the authors independently
extracted all the relevant data. Disagreement was re-
solved by discussion with the third reviewer. Whenever
necessary, we contacted the authors of the studies for
missing data or further information. The following data
were extracted: (1) demographic data of participants; (2)
indication for THA; (3) wound infection (superficial or
deep), hematoma, wound dehiscence, limb swelling, bleed-
ing from the wound, reoperation because of a wound-
healing complication; (4) postoperative blood transfusion,
decrease in hemoglobin or hematocrit, thromboembolic
complications, patient discomfort, costs; (5) functional
outcomes such as time to regain mobility; and (6) any
other outcomes as mentioned in individual studies were
considered for inclusion. In studies in which data were in-
complete or unclear, attempts were made to contact inves-
tigators for clarification.
Data analysis and statistical methods
The meta-analysis was undertaken using RevMan 5.1 for
Windows (The Cochrane Collaboration, Oxford, United
Kingdom). We assessed statistical heterogeneity for each
study with the use of a standard chi-square test (for het-
erogeneity, a level of P <0.1 was considered significant)
and the I2 statistic. An I2 statistic value of 50% was con-
sidered to indicate substantial heterogeneity. The origins
of heterogeneity, if present, were analyzed according to
differences in methodological quality, characteristics of
participants and intervention. When the data allowed,
the authors of this paper performed subgroup analysis of
the trials. If comparing trials showed heterogeneity, pooled
data were meta-analyzed using a random-effects model.
Otherwise, a fixed-effects model was used for the ana-
lysis. Relative risks (or risk differences) and 95% confi-
dence intervals (CIs) were calculated for dichotomous




We identified a total of 16 citations as potentially rele-
vant. By screening the title, and reading the abstract and
the entire article, we found that five RCTs enrolling a
total of 559 hips at final follow-up were eligible for data
extraction and meta-analysis [17-21] (Figure 1). The sam-
ple size for each study ranged from 50 to 200. Studies
were relatively well designed, and the quality assessment
score was high. However, the relevant RCTs had a number
of methodological weaknesses (Figures 2 and 3).
None of the RCTs provided randomization methods.
Two studies reported allocation concealment using sealed
envelopes [17,19]. Four studies attempted to blind the
subjects and assessors to group allocation [17-20]. Allstudies reported final outcomes for a minimum of 85% of
their randomized patients.
Inclusion and exclusion criteria were reported for all
studies. The patients’ characteristics were comparable
within each study group and are presented in Table 1.
Two studies reported a transfusion trigger, which was
related to a fall in either hemoglobin levels or clinical
symptoms [17,20]. The blood transfusion protocol was
not mentioned in three studies. For prophylaxis against
deep vein thrombosis, three studies used low-molecular-
Random sequence generation (selection bias)
Allocation concealment (selection bias)
Blinding of participants and personnel (performance bias)
Blinding of outcome assessment (detection bias)
Incomplete outcome data (attrition bias)
Selective reporting (reporting bias)
Other bias
0% 25% 50% 75% 100%
Low risk of bias Unclear risk of bias High risk of bias
Figure 3 Risk of bias. Each risk-of-bias item presented as percentages across all included studies, which indicated the proportion of different
levels of risk of bias for each item.
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pirin [20], and one study did not provide information.
Two studies mentioned anesthesia: one used spinal
anesthesia [18], and the other used general and spinal
anesthesia [21].
Different studies used different surgical approaches.
Zeh et al. reported that a minimally invasive modified
Watson-Jones approach and a standard Bauer approach
were performed. Morris et al. used an anterior supine
intermuscular approach. Falez et al. used a direct lateral
approach in the lateral position [18]. Marulanda et al.
used the anterolateral approach [19]. Barsoum et al. used
a standard posterior approach and a modified direct lat-
eral approach [17].Meta-analysis results
Hemoglobin drop
We obtained usable data on hemoglobin drop from
three trials including 390 hips [17,19,20]. As depicted in
Figure 4, there was no significant heterogeneity (χ2 = 1.31,
df =2, I2 = 0%, P =0.52). Using a fixed-effects model, the
pooled results indicated that there was no significant dif-
ference between the groups in terms of hemoglobin drop
(MD= −0.04, 95% CI: −0.33 to 0.25, P =0.77).Table 1 Characteristics of the included studies
Cases (BP/C) Mean age (BP/C) Male patien
Barsoum et al. (2011) [17] 71/69 55.4/55.7 36/38
Marulanda et al. (2008) [19] 25/25 57/56 13/14
Morris et al. (2013) [20] 100/100 63.5/61.3 48/48
Zeh et al. (2010) [21] 55/50 63.7/68.3 15/20
Falez et al. (2013) [18] 26/38 N/A N/A
N/A not available, DVT deep vein thrombosis.Hospital stay
Hospital stay was mentioned in three trials [17,19,21].
The pooled results showed no significant heterogeneity
(χ2 = 2.17, df =2, I2 = 8%, P =0.34; Figure 5); thus, a fixed-
effects model was used. Meta-analysis showed no signifi-
cant difference between the groups in terms of hospital
stay (MD= −0.16, 95% CI: −0.49 to 0.18, P =0.36).Infection
The incidence of infection was reported in two studies
[17,19]. The pooled results indicated that the incidence
of infection was 1.04% of hips (1/96) in the bipolar sealer
group, compared with 3.19% (3/94) in the conventional
group. This difference was significant (RR =0.42, 95% CI:
0.06 to 2.77, P =0.37; Figure 6). A fixed-effects model was
used because no statistical heterogeneity was found be-
tween the studies (χ2 = 0.05, df =1, I2 = 0%, P =0.83).Intraoperative blood loss
Intraoperative blood loss was documented in three studies
[17,20,21]. The difference between the groups was not
significant (MD =8.17, 95% CI: −9.39 to 25.73, P =0.36;
Figure 7). A fixed-effects model was used because nots (BP/C) Prosthesis DVT prophylaxis Length of follow-up
N/A Enoxaparin 12 weeks
N/A N/A N/A
N/A Aspirin 6 weeks
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Heterogeneity: Chi² = 4.00, df = 2 (P = 0.14); I² = 50%
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Figure 7 Forest plot showing the effect of bipolar sealer on infection.








Heterogeneity: Chi² = 3.25, df = 2 (P = 0.20); I² = 39%
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Favours bipolar sealer Favours standard electrocaute
Figure 8 Forest plot showing the effect of bipolar sealer on operative time.
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(χ2 = 4.00, df =2, I2 = 50%, P =0.14).
Need for transfusion
Need for transfusion was reported in three trials [17,19,20].
The pooled results showed a significant difference between
the groups (RR =0.72, 95% CI: 0.45 to 1.15, P =0.16). There
was no significant heterogeneity (χ2 = 3.25, df =2, I2 = 39%,
P =0.20; Figure 8). A fixed-effects model was used.
Operating time
Operative time was reported in two trials [17,21]. One
study mentioned that the use of bipolar sealer resulted in
a longer operative time (6 min), but did not give means
and standard deviations [19]. The pooled results of the
other trials showed that the use of bipolar sealer did not
extend operative time (MD= −4.37 min, 95% CI: −13.84
to 5.09, P =0.36) compared to that of conventional surgery
(Figure 9). A fixed-effects model was used because statis-
tical heterogeneity was found between the studies (χ2 =
0.76, df =1, I2 = 0%, P =0.38).
Other outcomes
Several other outcome measures were identified, but in-
sufficient data were provided for meta-analysis. For in-
stance, Barsoum et al. found that there were no significant
differences in the requirement for the number of units
transfused, Harris hip score, pain score, and Short Form-
12 score [17]. Marulanda et al. reported fewer units trans-
fused, less intraoperative blood loss, less drainage and less
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Figure 9 Forest plot showing the effect of bipolar sealer on need forstatistical differences in Harris hip score between the
two groups [19].
Discussion
The most important finding of the present meta-analysis
was that bipolar sealer in primary THA did not reduce
hemoglobin drop, intraoperative blood loss, need for
transfusion, and hospital stay. Furthermore, no signifi-
cant differences were found in operating time and infec-
tion. The effectiveness of bipolar sealer in primary THA
is questionable.
Five RCTs satisfied the defined eligibility criteria for this
meta-analysis. The overall methodological quality of the in-
cluded studies was relatively high. Although all of the stud-
ies reported randomization, none described the method of
randomization used. Therefore, the available information
left us unsure whether the right randomization methods
had been used. Two studies reported allocation conceal-
ment. Four studies attempted to blind the subjects and
assessors to group allocation, which reduced expectation
bias and the potential for type II statistical error in their
clinical outcomes. All included studies had consistent base-
line data, and intention to treat analysis was performed for
withdrawals and dropouts. These methodological strengths
and weaknesses should be considered when interpreting
the findings of the present meta-analysis.
Primary total hip replacement is complicated by peri-
operative blood loss ranging in amount from 1,000 to
2,000 ml. Blood transfusion was needed to correct anemia
in 3% to 50% of patients [22]. This meta-analysis showed
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hemoglobin drop (MD = −0.04, 95% CI: −0.33 to 0.25,
P =0.77) in primary THA compared with standard elec-
trocautery. Most of the included studies were consistent
with this result. Marulanda et al., contesting other au-
thors, demonstrated lower intraoperative blood loss and
hemoglobin drop with the use of a bipolar sealer; how-
ever, they did not provide standard deviation of intraop-
erative blood loss for meta-analysis.
In the present meta-analysis, we found that patients in
the standard electrocautery group were not significantly
more likely to receive an allogeneic blood transfusion
than those in the bipolar sealer group (RR =0.72, 95% CI:
0.45 to 1.15, P =0.16). Two of the included studies agreed.
This result contests that of Marulanda et al., who reported
that more patients in the control group needed transfusion
than did patients in the bipolar sealer group (52% vs. 20%).
Their finding may be due to greater total blood loss (1,067
vs. 662 ml) and hemoglobin drop (3.4 g/dl vs. 3.0 g/dl) in
the controls after THA.
Infection is relatively rare after THA but can be devastat-
ing in terms of morbidity and cost [23]. In theory, bipolar
sealer avoids the disadvantages of standard electrocautery.
This meta-analysis found no significant difference in the
incidence of infection, which was 1.04% with bipolar sealer
and 3.19% in controls; the overall infection rate was 2.1%.
The reported incidence of infection after THA ranges from
0.6% to 3% [24]. Because infection may also occur later, as-
sessment after a longer follow-up period may be required.
Three studies mentioned the mean and standard devi-
ation of the length of hospital stay, but the pooled data
in this meta-analysis found no significant differences,
which was consistent with their results. Two studies re-
ported the operating time. Our results also suggest that bi-
polar sealer did not significantly decrease operative time.
There are several potential limitations of our meta-
analysis. (1) Only five reports were included, and their
sample sizes were small, which may have affected our
conclusions. (2) The follow-up of patients in some of the
trials was unclear. Many patients were followed up in
the short term. This may have resulted in underreport-
ing of, for example, infection. (3) There were insufficient
data to support analyses of functional outcome scores,
cost, drainage, postoperative swelling, and pain relief as
had originally been planned. However, this is the first
systematic review to evaluate the administration of bipolar
sealer during THA by only including studies that have ap-
propriate control and study groups. All of the included
studies were high-quality RCTs with good homogeneity.
Conclusion
In summary, the using of bipolar sealer was not superior
to standard electrocautery in patients undergoing primary
THA. The use of bipolar sealer is not recommended inprimary THA. Because of the limited quality of the evi-
dence currently available, more high quality RCTs with
better experimental design, larger patient samples and
longer follow-up are required.
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